首页> 美国卫生研究院文献>World Journal of Gastroenterology >Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma
【2h】

Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma

机译:不可手术性肝细胞癌的手术间隔物置放和质子放疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Few potentially curative treatment options exist apart from hepatic resection for patients with huge hepatocellular carcinoma (HCC). Proton radiotherapy is a promising new modality which has an inherent anti-tumor effect against HCC. However, the application of proton radiotherapy for tumors adjacent to the gastrointestinal tract is restricted because the tolerance dose of the intestine is extremely low. A novel two-step treatment was developed with surgical spacer placement and subsequent proton radiotherapy to administer proton radiotherapy with curative intent. This report presents a case of a patient with a huge unresectable HCC treated by this method who achieved disease-free survival of more than 2 years. This new strategy may potentially be an innovative and standard therapy for unresectable HCC in the near future.
机译:对于具有巨大肝细胞癌(HCC)的患者,除了肝切除术以外,几乎没有其他可能的治疗方法。质子放疗是一种有前途的新疗法,对肝癌具有内在的抗肿瘤作用。然而,由于肠的耐受剂量极低,因此质子放射疗法在胃肠道附近的肿瘤中的应用受到限制。开发了一种新颖的两步疗法,其中包括放置手术间隔物和随后的质子放疗,以达到治愈目的进行质子放疗。本报告介绍了一例通过这种方法治疗的无法切除的巨大HCC患者,其无病生存期超过2年。这项新策略可能在不久的将来成为无法切除的HCC的创新和标准疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号